These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 28449677)

  • 1. Cystic fibrosis: current therapeutic targets and future approaches.
    Rafeeq MM; Murad HAS
    J Transl Med; 2017 Apr; 15(1):84. PubMed ID: 28449677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New horizons for cystic fibrosis treatment.
    Fajac I; De Boeck K
    Pharmacol Ther; 2017 Feb; 170():205-211. PubMed ID: 27916649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments targeting the basic defects in cystic fibrosis.
    Fajac I; Wainwright CE
    Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repairing the basic defect in cystic fibrosis - one approach is not enough.
    Farinha CM; Matos P
    FEBS J; 2016 Jan; 283(2):246-64. PubMed ID: 26416076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis.
    Elborn JS
    Lancet; 2016 Nov; 388(10059):2519-2531. PubMed ID: 27140670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis: current concepts.
    Abrons HL
    W V Med J; 1993 Jun; 89(6):236-40. PubMed ID: 7686701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystic fibrosis: new treatments targeting the CFTR protein].
    Fajac I; Sermet-Gaudelus I
    Rev Mal Respir; 2013 Apr; 30(4):255-61. PubMed ID: 23664284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.
    Durmowicz AG; Witzmann KA; Rosebraugh CJ; Chowdhury BA
    Chest; 2013 Jan; 143(1):14-18. PubMed ID: 23276841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
    Pettit RS
    Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
    Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
    Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFTR protein repair therapy in cystic fibrosis.
    Quintana-Gallego E; Delgado-Pecellín I; Calero Acuña C
    Arch Bronconeumol; 2014 Apr; 50(4):146-50. PubMed ID: 24095197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating the genetics of cystic fibrosis to personalized medicine.
    Corvol H; Thompson KE; Tabary O; le Rouzic P; Guillot L
    Transl Res; 2016 Feb; 168():40-49. PubMed ID: 25940043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cystic fibrosis--review].
    Jonsdottir B; Bergsteinsson H; Baldursson O
    Laeknabladid; 2008 Dec; 94(12):831-7. PubMed ID: 19182319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.